vs

Side-by-side financial comparison of CME Group (CME) and VEON Ltd. (VEON). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.1B, roughly 1.7× VEON Ltd.). VEON Ltd. runs the higher net margin — 55.9% vs 0.1%, a 55.9% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 5.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

VEON Ltd., also known as VEON Group, is a multinational telecommunication and digital services company. Headquartered in Dubai, the company is publicly traded on the U.S.-based NASDAQ stock exchange. VEON operates in six markets in Europe and Asia, including Bangladesh, Kazakhstan, Kyrgyzstan, Pakistan, Ukraine and Uzbekistan. Specific brands include Banglalink in Bangladesh, Jazz in Pakistan, Kyivstar in Ukraine, and units operating in Kazakhstan, Kyrgyzstan, and Uzbekistan under the Beeline...

CME vs VEON — Head-to-Head

Bigger by revenue
CME
CME
1.7× larger
CME
$1.9B
$1.1B
VEON
Growing faster (revenue YoY)
CME
CME
+8.6% gap
CME
14.5%
5.8%
VEON
Higher net margin
VEON
VEON
55.9% more per $
VEON
55.9%
0.1%
CME

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
CME
CME
VEON
VEON
Revenue
$1.9B
$1.1B
Net Profit
$1.2M
$608.0M
Gross Margin
Operating Margin
0.1%
75.4%
Net Margin
0.1%
55.9%
Revenue YoY
14.5%
5.8%
Net Profit YoY
20.7%
583.1%
EPS (diluted)
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
VEON
VEON
Q1 26
$1.9B
Q4 25
$1.6B
Q3 25
$1.5B
Q2 25
$1.7B
$1.1B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
$1.0B
Net Profit
CME
CME
VEON
VEON
Q1 26
$1.2M
Q4 25
$1.2B
Q3 25
$908.0M
Q2 25
$1.0B
$608.0M
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Q2 24
$883.2M
$89.0M
Operating Margin
CME
CME
VEON
VEON
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
75.4%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
27.1%
Net Margin
CME
CME
VEON
VEON
Q1 26
0.1%
Q4 25
71.7%
Q3 25
59.1%
Q2 25
60.6%
55.9%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
Q2 24
57.6%
8.7%
EPS (diluted)
CME
CME
VEON
VEON
Q1 26
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$2.81
$0.34
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
VEON
VEON
Cash + ST InvestmentsLiquidity on hand
$2.4B
$1.3B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$1.5B
Total Assets
$202.0B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
VEON
VEON
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
$1.3B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
$862.0M
Total Debt
CME
CME
VEON
VEON
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
VEON
VEON
Q1 26
Q4 25
$28.7B
Q3 25
$28.2B
Q2 25
$27.7B
$1.5B
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Q2 24
$27.6B
$1.1B
Total Assets
CME
CME
VEON
VEON
Q1 26
$202.0B
Q4 25
$198.4B
Q3 25
$187.1B
Q2 25
$179.9B
$8.5B
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B
Q2 24
$123.4B
$7.3B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons